Matches 1 - 50 out of 329 1 2 3 4 5 6 7 >
Match Document Document Title
7629356 Substituted pyrrolo[3,4-b]pyridinamines and pharmaceutical compositions  
This invention relates to substituted pyrrolo[3,4-b]pyridinamines having the structural formula IA below: and to their pharmaceutically acceptable salt, compositions and methods of use. These...
7625905 Octahydro-pyrrolo[3,4-c]pyrrole CCR5 receptor antagonists  
Chemokine receptor antagonists, in particular, 3,7-diazabicyclo[3.3.0]octane compounds according to formula (I) wherein R 1 -R 3 and Ar are as defined herein are antagonists of chemokine CCR5...
7615567 Compounds and methods for promoting smoking cessation  
Compounds and methods for promoting smoking cessation. The compounds may be used to treat a variety of other conditions and disease states.
7598236 Diazabicyclic central nervous system active agents  
Compounds of formula I pharmaceutical compositions of these compounds, and use of said compositions to control synaptic transmission in mammals.
7579362 Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists  
The present invention relates to 1-aza-bicycloalkyl derivatives of formula I, wherein X is CH 2 or a single bond; Y is a group of formula and wherein R has the meanings as defined in the...
7547722 Chemical compounds  
The invention relates to a group of novel thieno-pyrrole compounds of Formula (I): wherein: R 1 , R 2 , R 3 , R 4 and R 5 are as defined in the specification, which are useful as...
7538226 (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane  
The present invention discloses (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0] heptane, salts thereof, and its use to treat pain and other disorders associated with the nicotinic...
7511056 TGF-β inhibitors  
The present invention is directed to inhibitors of TGF-β of Formula I:
7501076 Fluorescent diketopyrrolopyrroles  
The present invention relates to fluorescent diketopyrrolopyrrole of the formula (I), a process for their preparation and their use for the preparation of inks, colorants, pigmented plastics for...
7498444 (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate  
The present invention relates to the salt (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0] heptane benzenesulfonate and to methods of preparing the salt.
7456289 Anti-tumor compounds  
Compounds of the following formula: wherein A, D, Q, T, U, V, W, X, Y, Z, R 1 , and are as defined herein. This invention also relates to a method of inhibiting tubulin polymerization, or...
7449447 Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus  
The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers, racemates or prodrug of said compound, or pharmaceutically acceptable salts or solvates of said...
7446122 Substituted indole derivatives  
Provided herein are indole derivatives, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.
7399765 Substituted diazabicycloalkane derivatives  
Compounds of formula (I) Z-Ar 1 —Ar 2 (I) wherein Z is a diazabicyclic...
7393867 Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase I  
The present invention discloses and claims compounds of formula (I) and formula (II), as inhibitors of human casein kinase Iε and methods for using said compounds for treating central nervous...
7390798 Carboxamide spirolactam CGRP receptor antagonists  
The present invention is directed to compounds of Formula I: I (where variables A 1 , A 2 , B, J, K, m, n, R 4 , R 5a , R 5b and R 5c are as defined herein) useful as antagonists of CGRP...
7384946 M3 muscarinic acetylcholine receptor antagonists  
Novel dimeric benzoazabicyclohepatane compounds, pharmaceutical compositions, processes for their preparation and use thereof in treating M 3 muscarinic acetylcholine receptor mediated diseases...
7351733 Tetrahydrocarbazole derivatives and their pharmaceutical use  
The present invention relates to novel compounds that are useful in the treatment of human papillomaviruses, and also to the methods for the making and use of such compounds.
7326793 Process for the preparation of diketopyrrolopyrroles  
The present invention relates to a process for the preparation of diketopyrrolopyrroles of the formula (I), wherein A1, A2, A3 and A4 are as defined in the description of the present invention, to...
7319106 Diazabicyclic central nervous system active agents  
Compounds of formula I pharmaceutical compositions of these compounds, and use of said compositions to control synaptic transmission in mammals.
7268158 6H-THIENO [2,3-b]pyrrole derivatives as antagonists of gonadotropin releasing hormone (GnRH)  
The invention relates to a group of novel thieno-pyrrole compounds of Formula (I): wherein: R 1 , R 2 , R 3 , R 4 and R 5 are as defined in the specification, which are useful as...
7265115 Diazabicyclic CNS active agents  
Compounds of formula I: or pharmaceutically acceptable salts thereof, are useful for controlling synaptic transmission in mammals.
7253168 Substituted 1-benzyl-4-substituted piperazine analogues  
Compounds of Formula I are provided, in which variables are as described herein: Such compounds may be used to modulate MCH binding to MCH receptors in vivo or in vitro, and are particularly...
7235567 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist  
A crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist compound, which exhibits a powder x-ray diffraction profile substantially the same as that shown in FIG. 1 , or which...
7173047 Benzo (f) insoindol derivatives and their use as ep4 receptor ligands  
Compounds of formula (I) and pharmaceutically acceptable derivatives thereof bind with high affinity to the EP4 receptor and are of use in the treatment or prevention of conditions such as a...
7153848 Inhibitors of HCV replication  
Indole compounds of Formula I are described. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV. Different forms and compositions...
7135484 Azabicyclic compounds are central nervous system active agents  
Compounds of formula (I) are novel CNS active agents that are useful for treating pain and for treating other disorders associated with the cholinergic system.
7132442 6H-thieno[2, 3-b]pyrrole derivatives as antagonists of gonadotropin releasing hormone (GnRH)  
The invention relates to a group of novel thieno-pyrrole compounds of Formula (I): wherein: R 1 , R 2 , R 3 , R 4 and R 5 are as defined in the specification, which are useful as gonadotrophin...
7122570 Tetrahydrocarbazol derivatives as ligands for G-protein-coupled receptors (GPCR)  
This invention provides new tetrahydrocarbazole derivatives that act as ligands for G-protein-coupled receptors (GPCR), especially as antagonists of the gonadotropin-releasing hormone (GnRH). A...
7094800 Cyanopyrrolidides, process for their preparation and their use as medicaments  
The invention relates to compounds of the formula I in which the radicals have the meanings stated in the text, their stereoisomeric forms, and their physiologically tolerated salts,...
7081458 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues  
Melanin concentrating hormone receptor ligands (especially 1-benzyl-4-aryl-piperazines, 1-benzyl-4-aryl-piperidines and related compounds), capable of modulating MCH receptor activity, are...
7071207 Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity  
This invention relates to 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives which have been found to suppress appetite and induce weight loss. The invention also provides methods for synthesis...
7053108 Indoline compounds  
A compound of formula (I): wherein: R 1 and R 2 together form a benzo ring optionally substituted by halogen or by alkyl, alkoxy, cyano, nitro, hydroxy, amino, alkylamino, dialkylamino or...
7041235 Fluorescent diketopyrrolopyrrole analogues  
The present invention relates to fluorescent diketopyrrolopyrrole analogues of the general formula (I), wherein A 1 and A 2 are C 1 –C 18 alkyl, C 2 –C 18 alkenyl, C 2 –C 18 alkynyl, C 5...
7041684 Selective β3 adrenergic agonists  
The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective β 3 receptor...
7022706 Pharmaceutical compositions and methods for use  
Pharmaceutical compositions incorporate compounds that are capable of affecting nicotinic cholinergic receptors. A wide variety of conditions and disorders, and particularly conditions and...
6949539 Admantane derivatives  
The invention provides compounds of general formula (I) in which m, A, R 1 and Ar have the meanings defined in the specification; a process for their preparation; pharmaceutical compositions...
6939867 β3 agonists and uses thereof  
Sulfamide compounds having formula (I) are described as well as their use in the treatment of diseases dependent on the signaling pathways associated with β-adrenergic receptors, such as obesity,...
6924297 Naphathalene derivatives which bind to the EP4 receptor  
Compounds of formula (I) and pharmaceutically acceptable derivatives thereof bind with high affinity to the EP4 receptor and are of use in the treatment or prevention of conditions such as a...
6852716 Substituted-aryl compounds for treatment of disease  
The invention provides compounds of Formula I: These compounds may be in the form of pharmaceutical salts or compositions, racemic mixtures, or pure enantiomers thereof. The compounds of...
6821964 Modulators of chemokine receptor activity  
Chemokine receptor antagonists, in particular, bicyclic diamine compounds of Formula (I) that act as antagonists of chemokine CCR2 and CCR3 receptors including pharmaceutical compositions and uses...
6759421 Indoline compounds, a process for their preparation and pharmaceutical compositions containing them  
A compound of formula (I): wherein: R 1 and R 2 together form a benzo ring optionally substituted by halogen or by alkyl, alkoxy, cyano, nitro, hydroxy, amino, alkylamino, dialkylamino or...
6723138 Preparation of diketopyrrolopyrrole pigments  
A process for preparing diketopyrrolopyrrole pigments comprises conducting the elementary steps of pigment synthesis (reaction and hydrolysis) in a miniaturized continuous reactor.
6716856 4,5,6,7-tetrahydroindazole derivatives as antitumor agents  
Compounds which are 4,5,6,7-tetrahydroindazole derivative formula (1), wherein the dotted line (x) represents a single or double bond; n is 0 or 1; R 1 , R 2 and R 3 have the meanings reported in...
6649613 Diacylhydrazine derivatives  
Diacylhydrazine derivatives of general formula (I) wherein X, Y, Z, R 1 , 2 and R 3 are as defined herein, and their physiologically acceptable salts or solvates thereof, are integrin...
6586452 C1 to C4 side chain modified nodulisporic acid analogs  
The present invention relates to novel nodulosporic acid derivatives, which are acaricidal, antiparasitic, insecticidal and anthelmintic agents.
6579878 Pharmaceutical compositions and methods for use  
Pharmaceutical compositions incorporate compounds that are capable of affecting nicotinic cholinergic receptors. A wide variety of conditions and disorders, and particularly conditions and...
6570019 Cationic pyrrolo-pyrrol-derivatives, method for producing them and colorants for keratin fibers, containing these compounds  
The object of the present invention are diketopyrrolopyrroles of the general formula (I) wherein, independently of one another, Q 1 and Q 2 represent an optionally substituted, aromatic,...
6562816 Substituted-heteroaryl-7-aza&lsqb 2.2.1&rsqb bicycloheptanes for the treatment of disease  
The invention provides compounds of Formula I: compounds of the Formula I: wherein R 1 , R 2 , R 4 , R 6 , X, and W are defined herein. These compounds may be in the form of pharmaceutical salts...
6538010 Compounds and methods for promoting smoking cessation  
Compounds and methods for promoting smoking cessation. The compounds may be used to treat a variety of other conditions and disease states.
Matches 1 - 50 out of 329 1 2 3 4 5 6 7 >